Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-03
1993-11-16
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546112, 536 271, 514 43, A61K 3144
Patent
active
052624250
ABSTRACT:
[4S-(4.alpha.,4a.beta.,5.beta.,6.alpha.,7.alpha.,7a.alpha.)]-Octahydro-1H-1 -pyrindine-4,5,6,7-tetrols and [4R-(4.alpha.,4a.alpha.,5.alpha.,6.beta.,7.beta.,7a.beta.)]-octahydro-1H-1 -pyrindine-4,5,6,7-tetrols are useful as inhibitors of alpha-mannosidase and are useful immunostimulants, chemoprotective and radioprotective agents and antimetastatic agents.
REFERENCES:
patent: 4031102 (1977-06-01), Curran et al.
Farr Robert A.
Kang Mohinder S.
Peet Norton P.
Sunkara Sai P.
Kishore G.
Merrell Dow Pharmaceuticals Inc.
Page Thurman K.
LandOfFree
.alpha.-mannosidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-mannosidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-mannosidase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22825